## Abstract ## BACKGROUND The optimal treatment strategy for elderly patients with advanced nonsmall cell lung carcinoma has not been defined to date. The authors performed a retrospective analysis of a Phase III trial that treated patients who had Stage IIIB or IV nonsmall cell lung carcinoma wit
Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma?
β Scribed by James E. Herndon II; Stewart Fleishman; Alice B. Kornblith; Michael Kosty; Mark R. Green; Jimmie Holland
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 112 KB
- Volume
- 85
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Background:
Several studies have recently reported on the importance of quality of life (qol) in predicting the survival of patients with lung carcinoma. to confirm these reports, the relationship between survival and qol, as measured by the european organization for research and treatment of cancer (eortc) quality of life questionnaire and duke-unc social support scale, was examined within a group of 206 patients with advanced nonsmall cell lung carcinoma treated in a randomized clinical trial conducted by the cancer and leukemia group b (calgb 8931).
Methods:
Patients completed the eortc instrument and the duke-unc social support scale at baseline in the clinic. the cox proportional hazards model was used to determine the incremental contribution qol provided in predicting survival beyond the effect of known clinical prognostic variables.
Results:
Clinical factors that were jointly predictive of poorer survival included low performance status, nonadenocarcinoma histology, presence of dyspnea, weight loss greater than 5%, albumin level less than 3.5 mg/dl, and adrenal metastases. univariate analyses showed that patient-reported eortc subscales describing increased pain, appetite loss, fatigue, lung carcinoma symptoms, poorer overall qol, and poorer physical functioning predicted significantly poorer survival. multivariate analyses showed that, after adjustment for clinical factors, overall qol was not a significant predictor of survival. rather, the only eortc subscale of prognostic importance was the pain subscale, in which a 40-point increase was associated with a 27% increase in the hazard rate.
Conclusions:
This study did not confirm the prognostic importance of overall qol. rather, after adjustment for significant clinical factors, a patient-provided pain report had the greatest prognostic importance.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND The aim of this study was to assess the relationship between the expression of the 27βkilodalton (kD) __bcl__β2 protein and survival among nonsmall cell lung carcinoma (NSCLC) patients. ## METHODS Paired tissue samples of histologically confirmed tumor and uninvolved lu
## Background: With preclinical evidence of synergy, this dose-finding trial examining the combination of docetaxel and vinorelbine given with prophylactic filgrastim for the treatment of patients with nonsmall cell lung carcinoma was undertaken. ## Methods: Twenty-seven patients with advanced no
BACKGROUND. Docetaxel and vinorelbine are active agents in the treatment of nonsmall cell lung carcinoma (NSCLC). The efficacy and toxicity of this combination was evaluated in a Phase II study in patients with advanced NSCLC. ## METHODS. Forty-six chemotherapy-naive patients (44 men and 2 women
## Background: This meta-analysis was conducted to compare the effects of single agent versus combination chemotherapy on response rate, toxicity, and survival of patients with advanced nonsmall cell lung carcinoma (nsclc). ## Methods: The authors reviewed randomized clinical trials published in